Doxorubicin Hydrochloride Liposome in Treating Women With Ductal Carcinoma in Situ Undergoing Surgery
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: pegylated liposomal doxorubicin hydrochloride|GENETIC: DNA methylation analysis|GENETIC: TdT-mediated dUTP nick end labeling assay|GENETIC: fluorescence in situ hybridization|GENETIC: loss of heterozygosity analysis|GENETIC: polymerase chain reaction|OTHER: immunoenzyme technique|OTHER: immunohistochemistry staining method|OTHER: laboratory biomarker analysis|PROCEDURE: breast duct lavage|PROCEDURE: neoadjuvant therapy|PROCEDURE: therapeutic conventional surgery
Sponsor: Dr. Susan Love Research Foundation